- Content :Sorafinib
- Strength :200 mg,
- Form : ,Tablet
- Supply TypeManufacturer, Exporter, Supplier, Retailer
- Preferred Buyer Location All over the world
Nexavaruseful for the treatment of patients with renal cell carcinoma and primary liver cancer. It contains Sorafinib that is used for successfully treating the advanced renal and primary liver cancer. Sorafinib, a tyrosine protein kinase inhibitor significantly increases the chances of survival in hepatocellular carcinoma which is a common form of liver cancer.